RXMD - Progressive Care Inc. (RXMD) Technology Solutions May Spark Rapid Expansion
- RMXD news indicates that a synergistic tech-healthcare collaboration with potential to ignite both growth and revenues is in the works
- “Restructuring whiz” takes the helm as CEO, board chair
- Through technology and proven processes, Progressive Care helps simplify chaos, improve care and reduce costs
Recent developments bode well for the future of Progressive Care (OTCQB: RXMD). On a mission to snag ever more market share using data management and analytical tools, the well-established healthcare company might be on the cusp of breaking out of slow-growth mode and into rapid expansion. Several factors are at play that could prove meaningful for the company and its stakeholders.
Recent news from the company indicates that a synergistic tech-healthcare collaboration is in the works that has the potential to ignite both growth and revenues. In a series of rapid-fire announcements, Progressive Care...
NOTE TO INVESTORS: The latest news and updates relating to RXMD are available in the company’s newsroom at http://ibn.fm/RXMD
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to millions of social media followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text "Biotech" to 844-397-5787 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.